Back
Pfizer 10K Form
Sell
37
PFE
Pfizer
Last Price:
35.79
Seasonality Move:
3.77%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2021-05-13 | 10Q | PFE/Pfizer Quarterly |
| 2021-02-25 | 10K | PFE/Pfizer Annual |
| 2020-11-05 | 10Q | PFE/Pfizer Quarterly |
| 2020-08-06 | 10Q | PFE/Pfizer Quarterly |
| 2020-05-07 | 10Q | PFE/Pfizer Quarterly |
| 2020-02-27 | 10K | PFE/Pfizer Annual |
Receive PFE News And Ratings
See the #1 stock for the next 7 days that we like better than PFE
PFE Financial Statistics
Sales & Book Value
| Annual Sales: | $100.33B |
|---|---|
| Cash Flow: | $-2.12B |
| Price / Cash Flow: | 19.21 |
| Annual Sales: | $17.54 |
| Price / Book: | 2.04 |
Profitability
| EPS (TTM): | 3.76000 |
|---|---|
| Net Income (TTM): | $21.47B |
| Gross Margin: | $65.99B |
| Return on Equity: | 22.58% |
| Return on Assets: | 10.7% |
Pfizer Earnings Forecast
Key Pfizer Financial Ratios
- The Gross Profit Margin over the past 39 years for PFE is 65.77%.
- The Selling, General & Administrative Expenses for PFE have been equal to 13.63% of Gross Profit Margin.
- The Research & Development expenses have been 11.39% of Revenue.
- The Interest Expense is 3.95% of Operating Income.
- The Net Earning history of PFE is 31.27% of Total Revenues.
- Per Share Earnings over the last 39 years have been positive in 26 years.
Pfizer Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | S&P500 |
|---|---|
| Industry: | Drug Manufacturers - General |
| Sector: | Healthcare |
| Current Symbol: | PFE |
| CUSIP: | 717081 |
| Website: | pfizer.com |
Debt
| Debt-to-Equity Ratio: | 0.66 |
|---|---|
| Current Ratio: | 2.12 |
| Quick Ratio: | 1.68 |
Price-to-Earnings
| Trailing P/E Ratio: | 6.54 |
|---|---|
| Forward P/E Ratio: | 10.42 |